查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
数位PCR(dPCR)和实时PCR(qPCR)市场规模,份额和趋势分析：产品和服务,应用,最终用户,区域前景,竞争战略,按类别预测~2030
市场调查报告书
商品编码
1072844

数位PCR(dPCR)和实时PCR(qPCR)市场规模,份额和趋势分析：产品和服务,应用,最终用户,区域前景,竞争战略,按类别预测~2030

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size, Share & Trends Analysis By Product & service, By Application, By End-User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球数位 PCR (dPCR) 和实时 PCR (qPCR) 市场在预测期内将保持 8.8% 的复合年增长率，预计到 2030 年将增长到 113.9 亿美元。

先进的 PCR 技术、投资增加、遗传和传染病增加、生物标誌物分析在疾病诊断中的重要性增加以及蓬勃发展的人类基因组计划等因素正在推动市场的增长。另一方面，qPCR 和 dPCR 技术的技术限制以及昂贵的相关设备等问题可能会阻碍市场扩张。

本报告调查了全球数位 PCR (dPCR) 和实时 PCR (qPCR) 市场，包括市场概况、对市场增长的各种影响因素分析、市场规模趋势/预测以及各个类别/地区/细分按主要国家、主要公司概况等汇总。

目录

第一章介绍

第二章调查方法

第 3 章执行摘要

第四章市场动态

  • 成长因素、制约因素、机会、问题分析
  • COVID-19 的影响

第 5 章市场变量/展望

  • SWOT分析
  • PESTEL 分析
  • 波特五力分析
  • 热图分析

第 6 章全球 dPCR 和 qPCR 市场：按产品和服务分类

  • qPCR 产品与服务
    • qPCR试剂和耗材
    • qPCR设备
    • qPCR软件服务
  • dPCR 产品和服务
    • dPCR设备
    • dPCR 试剂和耗材
    • dPCR 软件服务

第 7 章全球 dPCR 和 qPCR 市场：按应用分类

  • qPCR
    • 临床
    • 法医学
    • 研究
  • dPCR
    • 临床
    • 研究
    • 法医学

第 8 章全球 dPCR 和 qPCR 市场：按最终用户分类

  • dPCR 最终用户
    • 临床研究所
    • 法医实验室
    • 医院/诊断中心
    • 製药和生物技术公司
    • 研究/学术机构
  • qPCR 最终用户
    • 临床研究所
    • 法医实验室
    • 医院/诊断中心
    • 製药和生物技术公司
    • 研究和学术机构

第 9 章全球 dPCR 和 qPCR 市场：按地区划分

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东/非洲

第 10 章公司简介

  • Abbott Laboratories
  • Agilent Technologies
  • Analytik Jena AG
  • Becton Dikinson and Company
  • bioMerieux SA
  • Bioneer
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • ELITech Group
  • Enzo Life Sciences, Inc.
  • Eppendorf
  • F. Hoffmann-La Roche, Ltd.
  • Fluidigm Corporation
  • Merck KGaA
  • Meridian Bioscience
  • Promega Corporation
  • QIAGEN N.V.
  • Quidel Corporation
  • Takara Bio
  • Thermo Fisher Scientific
简介目录
Product Code: BIOT2217

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market projected to be worth USD 11.39 billion by 2030.

According to SPER Market Research, the Digital PCR (dPCR) and Real-time PCR (qPCR) Market estimated to reach USD 11.39 billion by 2030 with a CAGR of 8.8%.

The key fuels for the market escalation are; advanced PCR technologies, growing investments, increasing genetic as well as targeted infectious disease, raising the exploit of biomarkers profiling in the disease diagnosis, and the booming Human Genome project.

Impact of COVID-19 on the Digital PCR (dPCR) and Real-time PCR (qPCR) Market

The COVID-19 outbreak has mainly impacted to the healthcare industry; diagnostic industry is one of them. There is a positive impact in the PCR industries. Digital PCR (dPCR) and Real-time PCR (qPCR) has the importance in the diagnostic and drug discovery. The focus of the companies is to produce digital PCR kits for the diagnosis of the infection.

Scope of the report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030

Segments covered By Product & Service, By Application, By End-User, By Region.

Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East, Africa

Companies Covered: Abbott Laboratories, Agilent Technologies, Analytik Jena AG, Becton, Dikinson and Compan, bioMerieux SA, Bioneer, Bio-Rad Laboratories Inc.Dan, aher Corporation, ELITech Group, Enzo Life Sciences, Inc., Eppendorf, F. Hoffmann-La Roche, Ltd., Fluidigm Corporation, Merck KGaA, Meridian Bioscience, Promega Corporation, QIAGEN N.V., Quidel Corporation, Thermo Fisher Scientific, Takara Bio

Driver: growing occurrence of target infectious diseases and genetic disorders

Rising incidence of target infectious diseases and genetic disorders, technological advancements in PCR technologies, increasing investments, funds, and grants, increasing use of biomarker profiling for disease diagnostics, successful completion of the Human Genome Project; are the key drives of the escalation of the market.

Restraint: High device costs coupled with dPCR

Technical limitations of qPCR and dPCR techniques, costly device coupled with dPCR; can resist the escalation of the market.

Opportunity: rising market penetration in emerging countries

Growing market penetration in emerging countries, shift from plant-derived to genome-based drug discovery; offers enormous opportunities to the players in the market.

Challenges:

Adoption and implementation of MIQE guidelines, is the challenge to the market expansion.

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By Product & Service:

Based on the Product and Service, Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is segmended as; qPCR Products & Services (qPCR Reagents and Consumables, qPCR Instruments, qPCR Software and Services), dPCR Products & Services (dPCR Instruments, dPCR Reagents and Consumables, dPCR Software and Services).

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By Application:

Based on the Application, Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is segmended as; qPCR Applications (Clinical Applications, Forensic Applications, Research Applications), dPCR Applications (Clinical Applications, Research Applications, Forensic Applications).

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By End-User:

Based on the End-User, Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is segmended as; qPCR End User (Clinical Research Organizations, Forensic Laboratories, Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes), qPCR End User (Clinical Research Organizations, Forensic Laboratories, Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes).

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By Region:

North America, dominates the principal share of this market; and this is because of accessibility to research & development funding, growing acceptance of innovative and novel genomic analysis, escalating use of PCR techniques in the clinical diagnostics, forensics, and commercialization of qPCR/dPCR products.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Digital PCR (dPCR) and Real-time PCR (qPCR) Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By Product & Service, 2019-2030 (USD Million)

  • 6.1. qPCR Products & Services
    • 6.1.1. qPCR Reagents and Consumables
    • 6.1.2. qPCR Instruments
    • 6.1.3. qPCR Software and Services
  • 6.2. dPCR Products & Services
    • 6.2.1. dPCR Instruments
    • 6.2.2. dPCR Reagents and Consumables
    • 6.2.3. dPCR Software and Services

7. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By Application, 2019-2030 (USD Million)

  • 7.1. qPCR Applications
    • 7.1.1. Clinical Applications
    • 7.1.2. Forensic Applications
    • 7.1.3. Research Applications
  • 7.2. dPCR Applications
    • 7.2.1. Clinical Applications
    • 7.2.2. Research Applications
    • 7.2.3. Forensic Applications

8. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By End-User, 2019-2030 (USD Million)

  • 8.1. dPCR End User
    • 8.1.1. Clinical Research Organizations
    • 8.1.2. Forensic Laboratories
    • 8.1.3. Hospitals and Diagnostic Centers
    • 8.1.4. Pharmaceutical and Biotechnology Companies
    • 8.1.5. Research Laboratories and Academic Institutes
  • 8.2. qPCR End User
    • 8.2.1. Clinical Research Organizations
    • 8.2.2. Forensic Laboratories
    • 8.2.3. Hospitals and Diagnostic Centers
    • 8.2.4. Pharmaceutical and Biotechnology Companies
    • 8.2.5. Research Laboratories and Academic Institutes

9. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market, By Region, 2019-2030 (USD Million)

  • 9.1. North America
    • 9.1.1. United States
    • 9.1.2. Canada
    • 9.1.3. Mexico
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. United Kingdom
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Australia
    • 9.3.5. South Korea
    • 9.3.6. Rest of Asia-Pacific
  • 9.4. South America
  • 9.5. Middle East & Africa
    • 9.5.1. Kingdom of Saudi Arabia
    • 9.5.2. United Arab Emirates
    • 9.5.3. Rest of Middle East & Africa

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company details
    • 10.1.2. Financial outlook
    • 10.1.3. Product summary
    • 10.1.4. Recent developments
  • 10.2. Agilent Technologies
    • 10.2.1. Company details
    • 10.2.2. Financial outlook
    • 10.2.3. Product summary
    • 10.2.4. Recent developments
  • 10.3. Analytik Jena AG
    • 10.3.1. Company details
    • 10.3.2. Financial outlook
    • 10.3.3. Product summary
    • 10.3.4. Recent developments
  • 10.4. Becton Dikinson and Company
    • 10.4.1. Company details
    • 10.4.2. Financial outlook
    • 10.4.3. Product summary
    • 10.4.4. Recent developments
  • 10.5. bioMerieux SA
    • 10.5.1. Company details
    • 10.5.2. Financial outlook
    • 10.5.3. Product summary
    • 10.5.4. Recent developments
  • 10.6. Bioneer
    • 10.6.1. Company details
    • 10.6.2. Financial outlook
    • 10.6.3. Product summary
    • 10.6.4. Recent developments
  • 10.7. Bio-Rad Laboratories Inc.
    • 10.7.1. Company details
    • 10.7.2. Financial outlook
    • 10.7.3. Product summary
    • 10.7.4. Recent developments
  • 10.8. Danaher Corporation
    • 10.8.1. Company details
    • 10.8.2. Financial outlook
    • 10.8.3. Product summary
    • 10.8.4. Recent developments
  • 10.9. ELITech Group
    • 10.9.1. Company details
    • 10.9.2. Financial outlook
    • 10.9.3. Product summary
    • 10.9.4. Recent developments
  • 10.10. Enzo Life Sciences, Inc.
    • 10.10.1. Company details
    • 10.10.2. Financial outlook
    • 10.10.3. Product summary
    • 10.10.4. Recent developments
  • 10.11. Eppendorf
    • 10.11.1. Company details
    • 10.11.2. Financial outlook
    • 10.11.3. Product summary
    • 10.11.4. Recent developments
  • 10.12. F. Hoffmann-La Roche, Ltd.
    • 10.12.1. Company details
    • 10.12.2. Financial outlook
    • 10.12.3. Product summary
    • 10.12.4. Recent developments
  • 10.13. Fluidigm Corporation
    • 10.13.1. Company details
    • 10.13.2. Financial outlook
    • 10.13.3. Product summary
    • 10.13.4. Recent developments
  • 10.14. Merck KGaA
    • 10.14.1. Company details
    • 10.14.2. Financial outlook
    • 10.14.3. Product summary
    • 10.14.4. Recent developments
  • 10.15. Meridian Bioscience
    • 10.15.1. Company details
    • 10.15.2. Financial outlook
    • 10.15.3. Product summary
    • 10.15.4. Recent developments
  • 10.16. Promega Corporation
    • 10.16.1. Company details
    • 10.16.2. Financial outlook
    • 10.16.3. Product summary
    • 10.16.4. Recent developments
  • 10.17. QIAGEN N.V.
    • 10.17.1. Company details
    • 10.17.2. Financial outlook
    • 10.17.3. Product summary
    • 10.17.4. Recent developments
  • 10.18. Quidel Corporation
    • 10.18.1. Company details
    • 10.18.2. Financial outlook
    • 10.18.3. Product summary
    • 10.18.4. Recent developments
  • 10.19. Takara Bio
    • 10.19.1. Company details
    • 10.19.2. Financial outlook
    • 10.19.3. Product summary
    • 10.19.4. Recent developments
  • 10.20. Thermo Fisher Scientific
    • 10.20.1. Company details
    • 10.20.2. Financial outlook
    • 10.20.3. Product summary
    • 10.20.4. Recent developments